Boston Scientific (NYSE: BSX) announced today that CMS granted reimbursement for its Agent drug-coated balloon (DCB).

Carlsmed (Nasdaq:CARL) today announced new technology add-on payment (NTAP) reimbursement for its spine implant technology.

Orchestra BioMed (Nasdaq:OBIO) today announced the pricing of an underwritten public offering totaling proceeds of ...

Ultromics announced that it raised $55 million in a Series C financing to support its AI-powered heart failure diagnostic ...

Baxter (NYSE: BAX) + shares fell sharply today on second-quarter results that came up shy of the consensus forecast. Shares ...